289 related articles for article (PubMed ID: 22303809)
1. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
2. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
Lu JJ; Wu ZH; Ping QN
Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693
[TBL] [Abstract][Full Text] [Related]
3. Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis.
Yao C; Wang W; Zhou X; Qu T; Mu H; Liang R; Wang A; Sun K
J Ocul Pharmacol Ther; 2011 Dec; 27(6):565-9. PubMed ID: 21895496
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system.
Yao W; Sun K; Mu H; Liang N; Liu Y; Yao C; Liang R; Wang A
Drug Dev Ind Pharm; 2010 Sep; 36(9):1027-35. PubMed ID: 20545508
[TBL] [Abstract][Full Text] [Related]
5. Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin.
Yao WJ; Sun KX; Liu Y; Liang N; Mu HJ; Yao C; Liang RC; Wang AP
Biol Pharm Bull; 2010; 33(8):1371-7. PubMed ID: 20686234
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
[TBL] [Abstract][Full Text] [Related]
8. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2.5 and G3.5--in vitro and in vivo study.
Borowska K; Wołowiec S; Głowniak K; Sieniawska E; Radej S
Int J Pharm; 2012 Oct; 436(1-2):764-70. PubMed ID: 22884834
[TBL] [Abstract][Full Text] [Related]
10. [Corneal penetration of PAMAM dendrimers-coated puerarin liposomes].
Liu Y; Sun K; Yao W; Liang N; Mu H; Liang R; Yao C
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(1):30-4. PubMed ID: 20349711
[TBL] [Abstract][Full Text] [Related]
11. Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin.
Huang X; Wu Z; Gao W; Chen Q; Yu B
Drug Dev Ind Pharm; 2011 Apr; 37(4):419-27. PubMed ID: 20942611
[TBL] [Abstract][Full Text] [Related]
12. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
13. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers.
Filipowicz A; Wołowiec S
Int J Pharm; 2011 Apr; 408(1-2):152-6. PubMed ID: 21272625
[TBL] [Abstract][Full Text] [Related]
14. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
[TBL] [Abstract][Full Text] [Related]
15. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
[TBL] [Abstract][Full Text] [Related]
16. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
19. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
20. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
